CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-13 | Finney Michael J. Director | Grant or award | +16,000 | 702,840 | ||
| 2025-06-13 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2024-06-11 | Finney Michael J. Director | Grant or award | +16,000 | 686,840 | ||
| 2024-06-11 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +95,400 | 95,400 | ||
| 2023-06-26 | Finney Michael J. Director | Grant or award | +7,375 | 670,840 | ||
| 2023-06-26 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +44,224 | 44,224 | ||
| 2022-08-04 | Finney Michael J. Director | Grant or award | +7,375 | 663,465 | ||
| 2022-08-04 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +44,224 | 44,224 | ||
| 2021-06-18 | Finney Michael J. Director | Exercise or conversion | +9,000 | $0.68 | $6K | 461,572 |
| 2021-06-18 | Finney Michael J. Director | Exercise or conversion | +12,700 | $0.68 | $9K | 474,272 |
| 2021-06-18 | Finney Michael J. Director | Option exercise | +181,818 | $1.10 | $200K | 656,090 |
| 2021-06-18 | Finney Michael J. Director | Exercise or conversion · Stock Option (right to buy) | −9,000 | 0 | ||
| 2021-06-18 | Finney Michael J. Director | Exercise or conversion · Stock Option (right to buy) | −12,700 | 0 | ||
| 2021-06-18 | Finney Michael J. Director | Option exercise · Common Stock Purchase Warrant | −181,818 | 0 | ||
| 2021-06-16 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +15,097 | 15,097 | ||
| 2020-06-08 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +65,700 | 65,700 | ||
| 2019-06-12 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +9,000 | 9,000 | ||
| 2019-06-12 | Finney Michael J. Director | Grant or award · Stock Option (right to buy) | +12,700 | 12,700 | ||
| 2019-04-11 | Finney Michael J. Director | Purchase | +181,818 | $1.10 | $200K | 452,572 |
| 2019-04-11 | Finney Michael J. Director | Purchase · Common Stock Warrant | +181,818 | $1.10 | $200K | 181,818 |
Page 1 of 2 · 28 trades